LONGHI, ANTONELLA
LONGHI, ANTONELLA
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
2023 Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini, E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2)
2022 Palmerini E.; Meazza C.; Tamburini A.; Bisogno G.; Ferraresi V.; Asaftei S.D.; Milano G.M.; Coccoli L.; Manzitti C.; Luksch R.; Serra M.; Gambarotti M.; Donati D.M.; Scotlandi K.; Bertulli R.; Favre C.; Longhi A.; Abate M.E.; Perrotta S.; Mascarin M.; D'Angelo P.; Cesari M.; Staals E.L.; Marchesi E.; Carretta E.; Ibrahim T.; Casali P.G.; Picci P.; Fagioli F.; Ferrari S.
Chondroblastoma's lung metastases treated with denosumab in pediatric patient
2021 Focaccia M.; Gambarotti M.; Hakim R.; Paioli A.; Cesari M.; Spazzoli B.; Spinnato P.; Donati D.; Rocca M.; Longhi A.
Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target
2021 Cortini M.; Armirotti A.; Columbaro M.; Longo D.L.; Di Pompo G.; Cannas E.; Maresca A.; Errani C.; Longhi A.; Righi A.; Carelli V.; Baldini N.; Avnet S.
Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
2019 Palmerini E.; Torricelli E.; Cascinu S.; Pierini M.; De Paolis M.; Donati D.; Cesari M.; Longhi A.; Abate M.; Paioli A.; Setola E.; Ferrari S.
Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience
2019 Abate, ME; Paioli, A; Cesari, M; Longhi, A; Palmerini, E; Setola, E; Carretta, E; Cammelli, S; Ronchi, L; Rocca, M; Manfrini, M; Scotlandi, K; Donati, DM
Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery
2003 Bacci G.; Ferrari S.; Longhi A.; Versari M.; Forni C.; Donati D.; Manfrini M.; Trentani P.; Barbieri E.
Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis
2003 Bacci G.; Ferrari S.; Mercuri M.; Longhi A.; Giacomini S.; Forni C.; Bertoni F.; Manfrini M.; Barbieri E.; Lari S.; Donati D.
Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity: Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor
2003 Bacci G.; Bertoni F.; Longhi A.; Ferrari S.; Forni C.; Biagini R.; Bacchini P.; Donati D.; Manfrini M.; Bernini G.; Lari S.
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: Recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide
2003 Bacci G.; Briccoli A.; Rocca M.; Ferrari S.; Donati D.; Longhi A.; Bertoni F.; Bacchini P.; Giacomini S.; Forni C.; Manfrini M.; Galletti S.
Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: Local and systemic control by amputation or limb salvage after preoperative chemotherapy
2003 Bacci G.; Ferrari S.; Longhi A.; Donati D.; Manfrini M.; Giacomini S.; Briccoli A.; Forni C.; Galletti S.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience | Setola, Elisabetta; Benini, S; Righi, A; Gamberi, G; Carretta, E; Ferrari, C; Avnet, S; Palmerini..., E; Magagnoli, G; Gambarotti, M; Lollini, P L; Cesari, M; Cocchi, S; Paioli, A; Longhi, A; Scotlandi, K; Laginestra, M A; Donati, D M; Baldini, N; Ibrahim, T | 2023-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | Setola Chondrosarcomapdf.pdf |
| Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2) | Palmerini E.; Meazza C.; Tamburini A.; Bisogno G.; Ferraresi V.; Asaftei S.D.; Milano G.M.; Cocco...li L.; Manzitti C.; Luksch R.; Serra M.; Gambarotti M.; Donati D.M.; Scotlandi K.; Bertulli R.; Favre C.; Longhi A.; Abate M.E.; Perrotta S.; Mascarin M.; D'Angelo P.; Cesari M.; Staals E.L.; Marchesi E.; Carretta E.; Ibrahim T.; Casali P.G.; Picci P.; Fagioli F.; Ferrari S. | 2022-01-01 | CANCER | - | 1.01 Articolo in rivista | Cancer - 2022 - Palmerini.pdf; cncr34131-sup-0002-tables1.zip |
| Chondroblastoma's lung metastases treated with denosumab in pediatric patient | Focaccia M.; Gambarotti M.; Hakim R.; Paioli A.; Cesari M.; Spazzoli B.; Spinnato P.; Donati D.; ...Rocca M.; Longhi A. | 2021-01-01 | CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | crt-2020-384.pdf; file supplementari (2).zip |
| Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target | Cortini M.; Armirotti A.; Columbaro M.; Longo D.L.; Di Pompo G.; Cannas E.; Maresca A.; Errani C....; Longhi A.; Righi A.; Carelli V.; Baldini N.; Avnet S. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-00311-v3.pdf |
| Is there a role for chemotherapy after local relapse in high-grade osteosarcoma? | Palmerini E.; Torricelli E.; Cascinu S.; Pierini M.; De Paolis M.; Donati D.; Cesari M.; Longhi A....; Abate M.; Paioli A.; Setola E.; Ferrari S. | 2019-01-01 | PEDIATRIC BLOOD & CANCER | - | 1.01 Articolo in rivista | - |
| Toxicity and efficacy of busulfan-melphalan (BuMel) compared to treosulfan-melphalan (TreoMel) high dose chemotherapy (HDCT) consolidation in high-risk Ewing sarcoma (ES): A 12-year monoinstitutional experience | Abate, ME; Paioli, A; Cesari, M; Longhi, A; Palmerini, E; Setola, E; Carretta, E; Cammelli, S; Ro...nchi, L; Rocca, M; Manfrini, M; Scotlandi, K; Donati, DM | 2019-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.06 Abstract in rivista | - |
| Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery | Bacci G.; Ferrari S.; Longhi A.; Versari M.; Forni C.; Donati D.; Manfrini M.; Trentani P.; Barbi...eri E. | 2003-01-01 | JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | - | 1.03 Recensione in rivista | - |
| Multimodal therapy for the treatment of nonmetastatic Ewing sarcoma of pelvis | Bacci G.; Ferrari S.; Mercuri M.; Longhi A.; Giacomini S.; Forni C.; Bertoni F.; Manfrini M.; Bar...bieri E.; Lari S.; Donati D. | 2003-01-01 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity: Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor | Bacci G.; Bertoni F.; Longhi A.; Ferrari S.; Forni C.; Biagini R.; Bacchini P.; Donati D.; Manfri...ni M.; Bernini G.; Lari S. | 2003-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: Recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide | Bacci G.; Briccoli A.; Rocca M.; Ferrari S.; Donati D.; Longhi A.; Bertoni F.; Bacchini P.; Giaco...mini S.; Forni C.; Manfrini M.; Galletti S. | 2003-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: Local and systemic control by amputation or limb salvage after preoperative chemotherapy | Bacci G.; Ferrari S.; Longhi A.; Donati D.; Manfrini M.; Giacomini S.; Briccoli A.; Forni C.; Gal...letti S. | 2003-01-01 | ACTA ORTHOPAEDICA SCANDINAVICA | - | 1.01 Articolo in rivista | - |